A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,929
- 试验地点
- 10
- 主要终点
- Overall survival
研究概览
简要总结
The trial was designed to compare the effectiveness of radical resections of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies in the patients with N2 non-small cell lung cancer
详细描述
The trial is a multi-centre real-world non-interventional observational study. The Chinese patients with N2 non-small cell lung cancer enrolled from 2014 to 2017 who received radical resections of lung cancer and adjuvant chemotherapies will be included in the study and the study data on patient demographic/tumor biological characteristics and clinical treatment will be collected to evaluate compare effectiveness of radical resection of lung cancer plus adjuvant chemotherapies and perioperative chemotherapies after surgeries.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with radical resection of lung cancer enrolled from 2014 to 2019;
- •Pathologically diagnosed patients with non-small cell lung cancer;
- •Patients with age > 18 years old;
- •Patients who did not receive chest surgeries before hospitalization;
- •Patients with N2 lymph nodes (+) after surgeries;
- •Patients who received lymphadenectomy for one group or more groups of lymph nodes;
排除标准
- •Patients with second primary tumors or multiple primary tumors;
结局指标
主要结局
Overall survival
时间窗: 2014 - 2017
Overall survival
次要结局
- Disease-free survival(2014 - 2017)
研究者
lixiaofei
Professor
Tang-Du Hospital